Cue Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). 

CEO
Usman Azam
CEOUsman Azam
Employees
41
Employees41
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
41
Employees41

CUE Key Statistics

Market cap
35.12M
Market cap35.12M
Price-Earnings ratio
-0.83
Price-Earnings ratio-0.83
Dividend yield
Dividend yield
Average volume
2.13M
Average volume2.13M
High today
$0.42
High today$0.42
Low today
$0.3541
Low today$0.3541
Open price
$0.3806
Open price$0.3806
Volume
994.45K
Volume994.45K
52 Week high
$1.54
52 Week high$1.54
52 Week low
$0.2302
52 Week low$0.2302

Stock Snapshot

As of today, Cue Biopharma(CUE) shares are valued at $0.39. The company's market cap stands at 35.12M, with a P/E ratio of -0.83.

On 2026-01-24, Cue Biopharma(CUE) stock moved within a range of $0.35 to $0.42. With shares now at $0.39, the stock is trading +9.3% above its intraday low and -7.9% below the session's peak.

Trading activity shows a volume of 994.45K, compared to an average daily volume of 2.13M.

Over the past 52 weeks, Cue Biopharma(CUE) stock has traded between a high of $1.54 and a low of $0.23.

Over the past 52 weeks, Cue Biopharma(CUE) stock has traded between a high of $1.54 and a low of $0.23.

CUE News

TipRanks 2d
Cue Biopharma’s CUE-101 Trial Hits Completion: What It Means for Cancer Investors

Cue Biopharma (CUE) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tool...

People also own

Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.